Hearing outcome of sudden sensorineural hearing loss: long-term follow-up.
OBJECTIVE
To evaluate the time-dependent progress and delayed improvement in patients who were treated with combination therapy including oral corticosteroid for idiopathic sudden sensorineural hearing loss.


METHODS
This retrospective study at a secondary referral and university-based center included 156 patients who were treated by 10-day course of admission therapy and followed for at least three months.


RESULTS
Of 121 patients who recovered over three months of follow-up, 45.5% showed a delayed recovery after the end of 10-day course of therapy. Of these 55 patients, 78.2% recovered within one month, 5.5% recovered within one to two months, 12.7% recovered in two to three months, and 3.6% recovered later than three months after discharge.


CONCLUSIONS
This study describes the long-term results for a three-month retrospective series of 156 patients diagnosed with idiopathic sudden sensorineural hearing loss, although this result should be further studied by additional research.
Yeo
Sang-Won
SW
Department of Otolaryngology-Head and Neck Surgery, the Catholic University of Korea, College of Medicine, Uijeongbu St. Mary's Hospital, Gyeonggi-Do, Seoul, Korea.
Lee
Dong-Hee
DH
Jun
Beom-Cho
BC
Park
So-Young
SY
Park
Yong-Soo
YS
D000328:Adult; D001301:Audiometry, Pure-Tone; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D020127:Recovery of Function; D012189:Retrospective Studies; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use
D005938:Glucocorticoids; D014665:Vasodilator Agents; D011239:Prednisolone